Back to search

Article

Adrenal crisis mainly manifested as recurrent syncope secondary to Tislelizumab:a case report and literature review

2023-08-23

Abstract excerpt

As immune checkpoint inhibitors (ICIs), Tislelizumab is an anti-programmed cell death protein 1 (PD-1) drug. With the extensive application of ICIs, there is an ever-increasing proportion of immune-related adverse events (irAEs) in clinic, some of which may even be life-threatening. Herein we present a patient of Tislelizumab-induced adrenal crisis. The main clinical manifestation is recurrent syncope accompanied...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
012fde26-ded2-536b-a4e3-d636040c9833
DOI
10.21203/rs.3.rs-3234717/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Adrenal crisis mainly manifested as recurrent syncope secondary to Tislelizumab:a case report and literature reviewDOI 10.21203/rs.3.rs-3234717/v1
Select a neighboring publication to make it the new centre.